Selected research
Market Structure
Global Colchicine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Colchicine Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Colchicine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Colchicine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Colchicine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Colchicine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Colchicine Tablets include Takeda Pharmaceutical, KPC Pharmaceuticals, Hongyun Pharmaceutical, Beijing Jialin Pharmaceutical, Teva, Taj Pharma, Ria Generics, Prasco Laboratories and Camber Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Colchicine Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Colchicine Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Colchicine Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Colchicine Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Colchicine Tablets Segment by Company
Takeda Pharmaceutical
KPC Pharmaceuticals
Hongyun Pharmaceutical
Beijing Jialin Pharmaceutical
Teva
Taj Pharma
Ria Generics
Prasco Laboratories
Camber Pharma
Agepha Pharma
AdvaCare Pharm
Colchicine Tablets Segment by Type
1.0mg per Tablet
0.6mg per Tablet
0.5mg per Tablet
Colchicine Tablets Segment by Application
Familial Mediterranean Fever
Gout
Other
Colchicine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colchicine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colchicine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colchicine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Colchicine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colchicine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Colchicine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Colchicine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 1.0mg per Tablet
- 0.6mg per Tablet
- 0.5mg per Tablet
Applications
- Familial Mediterranean Fever
- Gout
- Other
Companies covered
- Takeda Pharmaceutical
- KPC Pharmaceuticals
- Hongyun Pharmaceutical
- Beijing Jialin Pharmaceutical
- Teva
- Taj Pharma
- Ria Generics
- Prasco Laboratories
- Camber Pharma
- Agepha Pharma
- AdvaCare Pharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Colchicine Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Colchicine Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Colchicine Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Colchicine Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Colchicine Tablets Market Dynamics
- 2.1 Colchicine Tablets Industry Trends
- 2.2 Colchicine Tablets Industry Drivers
- 2.3 Colchicine Tablets Industry Opportunities and Challenges
- 2.4 Colchicine Tablets Industry Restraints
3 Colchicine Tablets Market by Manufacturers
- 3.1 Global Colchicine Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Colchicine Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Colchicine Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Colchicine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Colchicine Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Colchicine Tablets Manufacturers, Product Type & Application
- 3.7 Global Colchicine Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Colchicine Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Colchicine Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Colchicine Tablets Tier 1, Tier 2, and Tier 3
4 Colchicine Tablets Market by Type
- 4.1 Colchicine Tablets Type Introduction
- 4.1.1 1.0mg per Tablet
- 4.1.2 0.6mg per Tablet
- 4.1.3 0.5mg per Tablet
- 4.2 Global Colchicine Tablets Sales by Type
- 4.2.1 Global Colchicine Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Colchicine Tablets Sales by Type (2021-2032)
- 4.2.3 Global Colchicine Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Colchicine Tablets Revenue by Type
- 4.3.1 Global Colchicine Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Colchicine Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Colchicine Tablets Revenue Market Share by Type (2021-2032)
5 Colchicine Tablets Market by Application
- 5.1 Colchicine Tablets Application Introduction
- 5.1.1 Familial Mediterranean Fever
- 5.1.2 Gout
- 5.1.3 Other
- 5.2 Global Colchicine Tablets Sales by Application
- 5.2.1 Global Colchicine Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Colchicine Tablets Sales by Application (2021-2032)
- 5.2.3 Global Colchicine Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Colchicine Tablets Revenue by Application
- 5.3.1 Global Colchicine Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Colchicine Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Colchicine Tablets Revenue Market Share by Application (2021-2032)
6 Global Colchicine Tablets Sales by Region
- 6.1 Global Colchicine Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Colchicine Tablets Sales by Region (2021-2032)
- 6.2.1 Global Colchicine Tablets Sales by Region (2021-2026)
- 6.2.2 Global Colchicine Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Colchicine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Colchicine Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Colchicine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Colchicine Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Colchicine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Colchicine Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Colchicine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Colchicine Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Colchicine Tablets Revenue by Region
- 7.1 Global Colchicine Tablets Revenue by Region
- 7.1.1 Global Colchicine Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Colchicine Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Colchicine Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Colchicine Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Colchicine Tablets Revenue (2021-2032)
- 7.2.2 North America Colchicine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Colchicine Tablets Revenue (2021-2032)
- 7.3.2 Europe Colchicine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Colchicine Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Colchicine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Colchicine Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Colchicine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Takeda Pharmaceutical
- 8.1.1 Takeda Pharmaceutical Company Information
- 8.1.2 Takeda Pharmaceutical Business Overview
- 8.1.3 Takeda Pharmaceutical Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Takeda Pharmaceutical Colchicine Tablets Product Portfolio
- 8.1.5 Takeda Pharmaceutical Recent Developments
- 8.2 KPC Pharmaceuticals
- 8.2.1 KPC Pharmaceuticals Company Information
- 8.2.2 KPC Pharmaceuticals Business Overview
- 8.2.3 KPC Pharmaceuticals Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 KPC Pharmaceuticals Colchicine Tablets Product Portfolio
- 8.2.5 KPC Pharmaceuticals Recent Developments
- 8.3 Hongyun Pharmaceutical
- 8.3.1 Hongyun Pharmaceutical Company Information
- 8.3.2 Hongyun Pharmaceutical Business Overview
- 8.3.3 Hongyun Pharmaceutical Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hongyun Pharmaceutical Colchicine Tablets Product Portfolio
- 8.3.5 Hongyun Pharmaceutical Recent Developments
- 8.4 Beijing Jialin Pharmaceutical
- 8.4.1 Beijing Jialin Pharmaceutical Company Information
- 8.4.2 Beijing Jialin Pharmaceutical Business Overview
- 8.4.3 Beijing Jialin Pharmaceutical Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Beijing Jialin Pharmaceutical Colchicine Tablets Product Portfolio
- 8.4.5 Beijing Jialin Pharmaceutical Recent Developments
- 8.5 Teva
- 8.5.1 Teva Company Information
- 8.5.2 Teva Business Overview
- 8.5.3 Teva Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Teva Colchicine Tablets Product Portfolio
- 8.5.5 Teva Recent Developments
- 8.6 Taj Pharma
- 8.6.1 Taj Pharma Company Information
- 8.6.2 Taj Pharma Business Overview
- 8.6.3 Taj Pharma Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Taj Pharma Colchicine Tablets Product Portfolio
- 8.6.5 Taj Pharma Recent Developments
- 8.7 Ria Generics
- 8.7.1 Ria Generics Company Information
- 8.7.2 Ria Generics Business Overview
- 8.7.3 Ria Generics Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Ria Generics Colchicine Tablets Product Portfolio
- 8.7.5 Ria Generics Recent Developments
- 8.8 Prasco Laboratories
- 8.8.1 Prasco Laboratories Company Information
- 8.8.2 Prasco Laboratories Business Overview
- 8.8.3 Prasco Laboratories Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Prasco Laboratories Colchicine Tablets Product Portfolio
- 8.8.5 Prasco Laboratories Recent Developments
- 8.9 Camber Pharma
- 8.9.1 Camber Pharma Company Information
- 8.9.2 Camber Pharma Business Overview
- 8.9.3 Camber Pharma Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Camber Pharma Colchicine Tablets Product Portfolio
- 8.9.5 Camber Pharma Recent Developments
- 8.10 Agepha Pharma
- 8.10.1 Agepha Pharma Company Information
- 8.10.2 Agepha Pharma Business Overview
- 8.10.3 Agepha Pharma Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Agepha Pharma Colchicine Tablets Product Portfolio
- 8.10.5 Agepha Pharma Recent Developments
- 8.11 AdvaCare Pharm
- 8.11.1 AdvaCare Pharm Company Information
- 8.11.2 AdvaCare Pharm Business Overview
- 8.11.3 AdvaCare Pharm Colchicine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 AdvaCare Pharm Colchicine Tablets Product Portfolio
- 8.11.5 AdvaCare Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Colchicine Tablets Value Chain Analysis
- 9.1.1 Colchicine Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Colchicine Tablets Production Mode & Process
- 9.2 Colchicine Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Colchicine Tablets Distributors
- 9.2.3 Colchicine Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst